Figure 2. Genome mapping distribution relative to input reads obtained from small RNA sequencing of exosomal RNA extracted from various plasma and serum samples using EXTRAClean Plasma/Serum Exosome and Free-Circulating RNA Isolation Mini Kit.

Figure 3. Average small RNA biotype distribution relative to the input reads obtained from sequencing of exosomal RNA extracted from various plasma and serum using EXTRAClean Plasma/Serum Exosome and Free-Circulating RNA Isolation Mini Kit.

Figure 4. Average read quality distribution relative to raw reads of small RNA sequencing of exosomal RNA extracted from plasma and serum samples using EXTRAClean Plasma/Serum Exosome and Free-Circulating RNA Isolation Midi Kit. Calculations were relative to raw reads.

Figure 5. Genome mapping distribution relative to input reads obtained from small RNA sequencing of exosomal RNA extracted from various plasma and serum samples using EXTRAClean Plasma/Serum Exosomeand Free-Circulating RNA Isolation Midi Kit.

Figure 6. Average small RNA biotype distribution relative to the input reads obtained from sequencing of exosomal RNA extracted from various plasma and serum using EXTRAClean Plasma/Serum Exosome and Free-Circulating RNA Isolation Maxi Kit.

Figure 7. Average read quality distribution relative to raw reads of small RNA sequencing of exosomal RNA extracted from plasma and serum samples using EXTRAClean Plasma/Serum Exosome and Free-Circulating RNA Isolation Maxi Kit. Calculations were relative to raw reads.

Figure 8. Genome mapping distribution relative to input reads obtained from small RNA sequencing of exosomal RNA extracted from various plasma and serum samples using EXTRAClean Plasma/Serum Exosome and Free-Circulating RNA Isolation Maxi Kit.

Figure 9. Average small RNA biotype distribution relative to the input reads obtained from sequencing of exosomal RNA extracted from various plasma and serum using EXTRAClean Plasma/Serum Exosome and Free-Circulating RNA Isolation Maxi Kit.